National Cancer Center Korea
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1989-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.ncc.re.kr
Clinical Trials
196
Active:8
Completed:75
Trial Phases
5 Phases
Phase 1:9
Phase 2:87
Phase 3:22
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (164 trials with phase data)• Click on a phase to view related trials
Phase 2
87 (53.0%)Not Applicable
44 (26.8%)Phase 3
22 (13.4%)Phase 1
9 (5.5%)Phase 4
2 (1.2%)Intravesical Hyaluronic Acid (HA) for Preventing Radiation Cystitis on Bladder Cancer
Not Applicable
Not yet recruiting
- Conditions
- Bladder CancerRadiation Cystitis
- First Posted Date
- 2025-08-15
- Last Posted Date
- 2025-08-15
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 54
- Registration Number
- NCT07125924
- Locations
- 🇰🇷
National Cancer Center, Korea, Goyang-si, Gyeonggi-do, Korea, Republic of
Patients With High-grade Pancreatic Neuroendocrine Tumors
Not Applicable
Active, not recruiting
- Conditions
- Neuroendocrine Tumor of PancreasPancreatic Neuroendocrine Tumors
- Interventions
- First Posted Date
- 2025-08-13
- Last Posted Date
- 2025-08-13
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 46
- Registration Number
- NCT07121478
- Locations
- 🇰🇷
National Cancer Center, Goyang-si, Gyeonggi-do, Korea, Republic of
Knowledge-enhanced Digital Intervention to Prevent Low Anterior Resection Syndrome
Not Applicable
Not yet recruiting
- Conditions
- Rectal Neoplasm
- First Posted Date
- 2025-06-27
- Last Posted Date
- 2025-06-27
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 320
- Registration Number
- NCT07041515
A Study to Evaluate the Effectiveness of a Web-based Tool for Fertility Preservation in Cancer Patients
Not Applicable
Not yet recruiting
- Conditions
- Infertility, FemaleNeoplasms
- First Posted Date
- 2025-06-26
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 32
- Registration Number
- NCT07038174
Necessity of TSH Suppression Therapy in Active Surveillance for Thyroid Cancer Patients.
Not Applicable
Not yet recruiting
- Conditions
- Thyroid CancerPapillary Thyroid Carcinoma
- Interventions
- First Posted Date
- 2025-05-14
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 578
- Registration Number
- NCT06971965
- Prev
- 1
- 2
- 3
- 4
- 5
- 40
- Next
News
No news found